NCT03113851 2023-06-13
Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer
Peking University Cancer Hospital & Institute
Phase 2 Completed
Clinical Trials
11 trialsNCT05501340 2022-08-15
PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites
Second Affiliated Hospital of Soochow University
Phase 1/2 Unknown
NCT01706458 2021-06-18
Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer
University of Wisconsin, Madison
Phase 2 Completed
NCT02411786 2021-02-04
A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF
University of Wisconsin, Madison
Phase 1 Completed
NCT01341652 2021-01-20
Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancer
University of Wisconsin, Madison
Phase 2 Completed
NCT00849121 2019-11-21
Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer
University of Wisconsin, Madison
Phase 2 Completed
NCT00582140 2019-11-19
Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer
University of Wisconsin, Madison
Phase 1 Completed
NCT02623595 2018-10-15
A Study of SBRT in Combination With rhGM-CSF for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy
Wuhan University
Phase 2 Withdrawn
NCT03489616 2018-04-05
CRAGMOLC
Shandong Cancer Hospital and Institute
Phase NA Unknown
NCT02466906 2016-01-20
RhGM-CSF as Adjuvant Immunotherapy in Treating Stage III Colon Cancer
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase 2 Unknown
NCT01806272 2013-03-29
Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral Mucositis
Sun Yat-sen University
Phase 2 Unknown